Previous Article | Next Article 
Molecular and Cellular Biology, September 2000, p. 6721-6730, Vol. 20, No. 18
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
HCF-1 Amino- and Carboxy-Terminal Subunit Association through Two
Separate Sets of Interaction Modules: Involvement of Fibronectin
Type 3 Repeats
Angus C.
Wilson,1,2
Michael
Boutros,1,
Kristina M.
Johnson,2,
and
Winship
Herr1,*
Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York 11724,1 and Department
of Microbiology and Kaplan Cancer Center, New York University
School of Medicine, New York, New York
100162
Received 6 March 2000/Returned for modification 9 April
2000/Accepted 9 June 2000
 |
ABSTRACT |
When herpes simplex virus infects permissive cells, the viral
regulatory protein VP16 forms a specific complex with HCF-1, a
preexisting nuclear protein involved in cell proliferation. The
majority of HCF-1 in the cell is a complex of associated amino (HCF-1N)- and carboxy (HCF-1C)-terminal
subunits that result from an unusual proteolytic processing of a large
precursor polypeptide. Here, we have characterized the structure and
function of sequences required for HCF-1N and
HCF-1C subunit association. HCF-1 contains two
matched pairs of self-association sequences called SAS1 and SAS2. One
of these matched association sequences, SAS1, consists of a short
43-amino-acid region of the HCF-1N subunit, which
associates with a carboxy-terminal region of the HCF-1C
subunit that is composed of a tandem pair of fibronectin type 3 repeats, a structural motif known to promote protein-protein
interactions. Unexpectedly, the related protein HCF-2, which is not
proteolyzed, also contains a functional SAS1 association element,
suggesting that this element does not function solely to maintain
HCF-1N and HCF-1C subunit association.
HCF-1N subunits do not possess a nuclear
localization signal. We show that, owing to a carboxy-terminal
HCF-1 nuclear localization signal, HCF-1C
subunits can recruit HCF-1N subunits to the nucleus.
 |
INTRODUCTION |
Lytic infection of human cells by
herpes simplex virus is characterized by a cascade of viral gene
expression initiated by the virion protein VP16 (reviewed in reference
22). Following infection of the host cell, the viral
transactivator VP16 (also known as Vmw65 and
TIF) is released from
the virion, whereupon it associates with two preexisting nuclear
factors, Oct-1 and HCF-1, to form a multiprotein-DNA complex on
VP16-responsive cis-regulatory elements in the viral
immediate-early promoters (8).
Oct-1 is a broadly expressed POU homeodomain-containing transcription
factor (24). The function of HCF-1 (also known as HCF,
C1, VCAF, and CFF) in the uninfected cell is less well understood. The
principal HCF-1 translation product is a large protein of 2,035 amino acids (12, 27), but only an amino-terminal region of
about 380 amino acids is essential for HCF-1 interaction with VP16
and stabilization of the VP16-induced complex with Oct-1 (10, 15,
26). Characterization of a temperature-sensitive hamster cell
line called tsBN67 has indicated that HCF-1 is involved in cell
proliferation (7): at nonpermissive temperature, tsBN67 cells stop proliferating owing to a missense mutation within the HCF-1 VP16 interaction region, which also inhibits HCF-1
association with VP16 (7, 26). The molecular mechanisms,
however, by which HCF-1 regulates cell proliferation are not known.
HCF-1 is a member of a protein family that includes the recently
described human protein HCF-2 (11), and both HCF-1
and HCF-2 are related to a protein in the worm Caenorhabditis
elegans called CeHCF (16). These three proteins have
conserved the VP16 interaction region and associate with
VP16 to differing extents (11, 16).
In mammalian cells, HCF-1 undergoes an unusual maturation process.
Its primary translation product is cleaved at a series of six conserved
26-amino-acid repeats called HCFPRO repeats located near
the center of the primary translation product (12, 27, 29). The resulting fragments, called HCF-1N
and HCF-1C, are stable, and they remain
noncovalently associated, creating a mature HCF-1 complex
(29). Although the majority of HCF-1N
and HCF-1C subunits remain noncovalently associated
after proteolysis, there is a variant HCF-1 translation product
called HCF-1
382-450, which results from removal
of an exon encoding amino-terminal HCF-1 residues 382 to 450 through alternative pre-mRNA processing; this smaller HCF-1 protein
undergoes proteolytic processing, but the resulting
HCF-1N and HCF-1C subunits do
not remain associated (29). Unlike the HCF-1 protein,
HCF-2 and CeHCF do not possess HCFPRO repeats, and
HCF-2 is not proteolytically cleaved like HCF-1
(11).
HCF-1 processing and the subsequent association of the resulting
HCF-1N and HCF-1C subunits are
unusual, and little is known concerning the mechanisms by which they
occur. Here, we describe aspects of human HCF-1N
and HCF-1C subunit association. Our
results show that the HCF-1N and
HCF-1C subunits contain two matched pairs of subunit
association elements and that subunit association can permit
recruitment of HCF-1N subunits to the nucleus via a
nuclear localization signal (NLS) located at the carboxyl terminus of the HCF-1C subunit. Unexpectedly, HCF-2,
which is not proteolyzed, shares one of the HCF-1 subunit
association elements, suggesting that the role of such an element is
not solely to maintain HCF-1N and
HCF-1C subunit association.
 |
MATERIALS AND METHODS |
Mammalian expression plasmids.
The hemagglutinin
(HA)-epitope-tagged human HCF expression constructs
pCGNHCFN1011
382-450, pCGNHCFN450-1011, pCGNHCFN450, and pCGNHCFN380 have been
described previously (26). pCGTHCFC
(C-terminal residues 1436 to 2035) is identical to pCGNHCFC (26) except that the influenza virus HA epitope is replaced by a bacteriophage T7 gene 10 (T7) epitope. To ensure detection and
protein stability, HCF-1 residues 348 to 450 or smaller
derivatives were expressed as fusions to the GAL4 DNA-binding domain
(residues 1 to 94) by subcloning into pCGNGAL4(1-94).
pCGTHCFSAS2C encodes HCF-1 residues 1436 to 1756, and
pCGTHCFSAS1C encodes residues 1758 to 2035. Truncations
were generated either by using suitable restriction sites or by PCR or
oligonucleotide-mediated mutagenesis. A fragment spanning residues 341 to 394 of human HCF-2 (11) was amplified using PCR and
subcloned into pCGNGAL4(1-94). The nucleotide sequences of
PCR-generated fragments were verified by DNA sequencing.
Sequence analysis.
Searches of the protein databases were
performed using BLASTP (1) and SMART (Simple Modular
Architecture Research Tool) (23). Sequence alignments were
compiled using ZEGA and CLUSTALW (provided on-line by the Molecular
Modeling and Bioinformatics Group, Skirball Institute, New York
University School of Medicine).
Transfections, immunoprecipitations, and immunoblotting.
Human 293 and 293T cells were transfected by electroporation or with
Lipofectamine (Gibco BRL, Inc.), respectively (11, 26).
Preparation of whole-cell nuclear extracts, immunoprecipitation, and
immunoblotting were performed as described previously (26).
Immunofluorescence.
293 cells were transfected by
electroporation and seeded onto sterile coverslips. After 36 h,
the coverslips were washed in phosphate-buffered saline (PBS); the
cells were fixed in 4% paraformaldehyde for 20 min and permeabilized
for 5 min with PBS containing 0.1% Triton X-100. The samples
were then washed three times with PBS and blocked for 30 min in PBS
containing 2% dry milk. After washing in PBS, coverslips were
incubated for 45 min with the primary antibody, washed, and incubated
with the secondary antibody for an additional 45 min. Fluorescence was
observed with a Nikon fluorescence microscope or a Zeiss confocal microscope.
 |
RESULTS |
Figure 1A shows a schematic of the structure of the
primary human HCF-1 translation product called
HCF-1300. HCF-1300 contains two
previously described sets of repeat elements: centrally located HCF-1PRO repeats and six amino-terminal kelch-like
repeats called HCF-1KEL, which likely fold into a
six-bladed
-propeller structure (residues 17 to 360 [15,
26]). Here, we analyzed the sequence of the carboxy-terminal
region of HCF-1, which was originally described as rich in charged
residues and the large hydrophobic residues tryptophan, tyrosine, and
phenylalanine (27). This region has been conserved in
evolution: both HCF-2 (11) and CeHCF (16)
share extensive sequence similarity to residues 1812 to 2001 of
HCF-1 (Fig. 1B). This region also exhibits internal sequence
similarity, which indicates a repeat of HCF-1 residues 1812 to 1875 and 1910 to 1992. These two sequences share a conserved tryptophan (W)
residue (positions 1812 and 1910) and the interdigitated sequence
FRXXXXNXXGXG, where "X" indicates any amino acid (residues 1864 to
1875 and 1981 to 1992 [Fig. 1B]).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 1.
HCF-1 contains two Fn3-like repeats. (A) Structural
features of human HCF-1 (hHCF-1). The six near-perfect
HCF-1PRO repeats (filled arrowheads) and two
degenerate nonfunctional repeats (open arrowheads) are indicated. The
amino-terminal -propeller domain involved in association with VP16
is represented as a shaded box. A carboxy-terminal domain rich in
charged or bulky hydrophobic residues (tryptophan, tyrosine, and
phenylalanine) is shown in greater detail. This region contains two
putative Fn3 repeats (HCF-1Fn31 and
HCF-1Fn32), indicated by filled arrows. A bipartite
NLS (filled box) lies at the very carboxyl terminus (13).
Regions with overall basic or acidic charge are also indicated. The
region 382-450 is deleted in a natural form of HCF-1 that
results from alternative splicing of the HCF-1 transcript. (B)
Alignment of the tandem HCF-1Fn31 and
HCF-1Fn32 repeats from the carboxy termini of
HCF-1, HCF-2, and CeHCF. The six perfectly conserved
positions (invariant residues) are highlighted in black, while residues
that are identical in each of the three HCF proteins are shaded. Small
arrows denote the limits of the HCF-1SAS1C element;
dots over the HCF-1 sequence indicate 10-amino-acid segments. (C)
Alignment of the four Fn3 repeats from the intracellular domain of
integrin 4. The positions of strands A through G2
(open arrows) are derived from the crystal structure of the tandem
Fn3-1 and Fn3-2 modules from integrin 6 4
(3). In close agreement with other Fn3 structures, strands A, B, and E and strands C, C', F, G1, and G2 form two sheets that pack as a sandwich, enclosing a hydrophobic core
(2). The invariant residues identified in
HCFFn31 and HCFFn32 (shown below the sequences)
are to a large extent conserved in all four modules of integrin
4.
|
|
A comparison of each carboxy-terminal repeat with other protein
sequences using the BLASTP program (1) and also the SMART database (23) revealed significant similarity to
fibronectin type 3 (Fn3) repeats. Fn3 repeats are typically 90 to
100 residues long and, although exhibiting relatively low primary amino
acid sequence similarity among different proteins, display considerable structural similarity (reviewed in reference 2).
Figure 1C shows a sequence alignment of four Fn3 repeats from the
4 subunit of
6
4 integrin.
The first two (Fn3-1 and Fn3-2) and second two (Fn3-3 and Fn3-4)
represent tandem repeats as with the two repeats in HCF-1. The
structure of the first set of tandem repeats has been determined
(3), and the positions of
strands in the structure are
shown in Fig. 1C. Together, Fig. 1B and C show the similarity of the
two carboxy-terminal HCF-1 repeats to Fn3 repeats. The predicted
Fn3 repeats in HCF-1 have also been identified independently by the
SMART database (http://smart.embl-heidelberg.de). These sequence
analyses identify for the first time a predicted structural element
within the carboxy-terminal region of HCF-1. We therefore refer to
these carboxy-terminal HCF-1 repeats as
HCF-1Fn31 and HCF-1Fn32.
The HCF-1N and HCF-1C
subunits readily associate when synthesized separately.
In the mature endogenous HCF-1 complex, the
noncovalently associated HCF-1N and
HCF-1C subunits result from proteolytic processing of the HCF-1300 precursor (29); thus,
the HCF-1N and HCF-1C subunits
are in close proximity for coassociation prior to proteolytic cleavage.
HCF-1N and HCF-1C subunit
association might, however, be regulated through sequential
dissociation and reassociation. To test the feasibility of such a
hypothesis, we asked whether dissociated HCF-1N and
HCF-1C subunits can associate without prior tethering as a single translation product.
We cotransfected human 293 cells with plasmids separately
encoding engineered HCF-1
N
(HCF-1
N1011) and HCF-1
C
(HCF-1
C600) subunits.
The
HCF-1
N subunit was tagged at its amino terminus
with an influenza
virus HA epitope, and the HCF-1
C
subunit was tagged at its amino
terminus with a T7 epitope. As a
positive control for protein-protein
association, we coexpressed the
HCF-1
N subunit with a T7-tagged
VP16 protein
(
26). Protein extracts were prepared from the transfected
cells, and the HA-tagged amino-terminal polypeptide was recovered
by immunoprecipitation with an anti-HA (

HA) monoclonal
antibody.
The resulting immune complexes were resolved on a sodium
dodecyl
sulfate (SDS)-polyacrylamide gel, and the coimmunoprecipitated
HCF-1
C and VP16 proteins were detected by
immunoblotting with
an

T7 monoclonal
antibody.
Figure
2 shows the result of such an experiment. Neither
VP16 nor the HCF-1
C subunit was recovered in the
absence of HA-HCF-1
N subunit expression (lanes 2 and 3), but both were recovered effectively
in the presence of the
full-length HCF-1
N subunit
HA-HCF-1
N1011 (compare lanes 4 and 5). This result
demonstrates that HCF-1
N and
HCF-1
C subunit association is not dependent on
coexpression
as the HCF-1
300 precursor and
indicates that the association of
HCF-1
N and
HCF-1
C subunits in endogenous HCF-1 can be
dynamic.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 2.
HCF-1 contains two N-terminal domains that can
mediate association with the C terminus. Extracts were prepared from
293 cells transfected with 5 µg of expression plasmids encoding
HA-tagged derivatives of the HCF-1N subunit and
with 2 µg of expression plasmids encoding a T7 epitope-tagged
version of either VP16 C (VP16) or the HCF-1C
subunit. HA-tagged polypeptides were recovered by immunoprecipitation
with an HA monoclonal antibody, resolved on an SDS-8%
polyacrylamide gel, and immunoblotted with an T7 tag antibody
(Novagen) to detect coimmunoprecipitated VP16 or
HCF-1C protein. The HA-tagged polypeptides were as
follows: mock (lanes 1 to 3), HCF-1N1011 (lanes 4 and
5), HCF-1N1011 382-450 (lanes 6 and 7),
HCF-1N450 (lanes 8 and 9),
HCF-1N450-1011 (lanes 10 and 11), and
HCF-1N380 (lanes 12 and 13). The structures of
HCF-1N and its derivatives used for
coimmunoprecipitation are shown schematically below. The ability (+) or
inability ( ) of each amino-terminal fragment to interact with VP16 or
HCF-1C is indicated.
|
|
The HCF-1N subunit contains two
HCF-1C subunit association regions.
We have
previously shown that the natural HCF-1 variant
HCF-1
382-450 (Fig. 1A) is processed normally,
but the resulting HCFN
382-450 and HCFC
subunits do not remain associated (29). Consistent with this
observation, when synthesized separately as shown in Fig. 2, an
HCF-1N subunit lacking residues 382 to 450 but
retaining the VP16 interaction region
(HCF-1N1011
382-450) bound VP16 (lane 6) but not
the engineered HCF-1C subunit (lane 7), suggesting
that loss of residues 382 to 450 disrupts sequences involved in
HCF-1N association with the
HCF-1C subunit.
To map more precisely the HCF-1
N region(s) involved
in HCF-1 subunit association, we divided the
HCF-1
N subunit into two segments,
with one
fragment containing residues 1 to 450 (HCF-1
N450)

thus
including the 382-450 region
involved in controlling HCF-1
C subunit
association

and the other spanning the remainder of the
HCF-1
N subunit
(HCF-1
N450-1011). Consistent with previous studies
(
26), the HCF-1
N450 protein (Fig.
2,
lane 8) but not the HCF-1
N450-1011 protein
(lane 10) associated with VP16. To our surprise, however,
both
nonoverlapping HCF-1
N derivatives associated with
the HCF-1
C subunit (lanes 9 and 11), suggesting that
the HCF-1
N subunit contains
two
HCF-1
C association sequences. We refer to the
regions involved
in HCF-1
N and
HCF-1
C subunit association as self-association
sequence
(SAS) elements; the SAS elements in
HCF-1
N450 and HCF-1
N450-1011 are referred to as HCF-1
SAS1N and
HCF-1
SAS2N,
respectively.
The presence of an HCF-1
N SAS element in the
HCF-1
N450-1011 fragment was unexpected because the
natural HCF-1
N
382-450 subunit encompasses all but
one residue of the HCF-1
N450-1011 fragment and yet
fails to associate with the HCF-1
C subunit (Fig.
2,
lane 7). Thus, loss of residues 382 to 450 in the
HCF-1
N subunit
appears to have a dominant negative
effect on the activity of
HCF-1
SAS2N element in
HCF-1
N450-1011. Given this unexpected
result, we
asked whether the HCF-1
SAS1N element in the
HCF-1
N450 fragment (lane 9) might reside within the
residues 1 to 380 (i.e.,
the VP16 interaction region), and its
activity also be inhibited
in the HCF-1
N
382-450
deletion variant, by assaying
the ability of an
HCF-1
N380 fragment to associate with the
HCF-1
C subunit. Consistent with previous results
(
26), the HCF-1
N380 fragment associated
with VP16 (lane 12); it failed, however, to
associate with the
HCF-1
C subunit (lane 13). Thus, the
HCF-1
SAS1N element does not reside entirely within
the VP16-interaction region,
and VP16 and HCF-1
C
subunit associations are different HCF-1
N activities.
The HCF-1C subunit contains two
independent HCF-1N association elements.
Given
the identification of two regions within the HCF-1N
subunit that can associate independently with the
HCF-1C subunit, HCF-1SAS1N and
HCF-1SAS2N, we asked whether these regions
might associate with the same region or different regions of the
HCF-1C subunit. In addition to the Fn3 repeats, the
HCF-1C subunit contains a region with more acidic
than basic residues (reference 37 and Fig. 1A). To
determine whether either the acidic or Fn3 repeat regions are involved
in HCF-1N subunit association, we divided the
HCF-1C subunit in two
residues 1436 to 1756 covering
the acidic region (HCF-1C1436-1756) and residues
1758 to 2035 covering the HCF-1Fn3 repeats
(HCF-1C1758-2035)
and tested each individually for association with the HCF-1N subunit as shown in
Fig. 3. In addition to associating with the full-length
HCF-1C subunit (lane 1) as expected, the
full-length HCF-1N subunit associated with both the
acidic HCF-1C1436-1756 (lane 2) and Fn3
repeat-containing HCF-1C1758-2035 (lane 3)
fragments, although recovery of the
HCF-1C1436-1756 fragment was considerably less
efficient, which may reflect inhibition by the amino-terminal region of
HCF-1 (see Discussion). In contrast, the alternative-splice variant HCF-1N
382-450 subunit associates neither with
the full-length HCF-1C subunit (lane 4), as
expected, nor with either HCF-1C subfragment (lanes
5 and 6) effectively. Thus, the full-length but not the splice-variant
HCF-1 can associate with two independent regions within the
carboxy-terminal HCF-1C subunit. We refer to the
most carboxy-terminal HCF-1C self-association
sequence in the HCF-1C1758-2035 segment as
HCF-1SAS1C and the more internal
HCF-1C self-association sequence in the
HCF-1C1436-1756 segment as
HCF-1SAS2C.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
HCF-1SAS1N and
HCF-1SAS2N interact with different regions of the
HCFC subunit. HA-tagged HCF-1N
fragments and T7-tagged HCFC fragments were coexpressed in
transfected 293 cells, and association was assayed by
immunoprecipitation with the HCF-1 antibody followed by
immunoblotting with the T7 antibody. The HA-tagged polypeptides were
as follows: HCF-1N1011 (lanes 1 to 3),
HCF-1N1011 382-450 (lanes 4 to 6),
HCF-1N450 (lanes 7 to 9), and
HCF-1N450-1011 (lanes 10 to 12). The T7-tagged
polypeptides were as follows: HCF-1C (lanes 1, 4, 7, and 10), HCF-1C1436-1756 (lanes 2, 5, 8, and
11), and HCF-1C1758-2035 (lanes 3, 6, 9, and 12).
|
|
Having identified two SAS elements in both the HCF
N and
HCF
C subunits, we asked whether there is any
specificity in the interaction
between the amino-terminal
HCF-1
SAS1N and HCF-1
SAS2N
elements
and the carboxy-terminal HCF-1
SAS1C and
HCF-1
SAS2C elements as
shown in Fig.
3. Indeed,
there is specificity: the
HCF-1
SAS1N-containing
HCF-1
N450
fragment associated only with the
HCF-1
SAS1C-containing
HCF-1
C1758-2035 fragment (compare lanes 7 to 9),
and the
HCF-1
SAS2N-containing
HCF-1
N450-1011 fragment associated
only with the
HCF-1
SAS2C-containing
HCF-1
C1436-1756 fragment
(compare lanes 10 to 12). Thus, HCF-1 displays two matched pairs
of SAS elements: the
most amino- and carboxy-terminal SAS
elements

HCF-1
SAS1N and
HCF-1
SAS1C
form one association complex, and the
more internal
SAS elements

HCF-1
SAS2N and
HCF-1
SAS2C
form a second association
complex. We do not know, however, whether both SAS1 and SAS2 mediate
HCF-1
N and HCF-1
C subunit
association simultaneously in native
HCF-1.
Mapping of the amino-terminal HCF-1SAS1N
and HCF-1SAS2N elements.
Using the strategy shown
in Fig. 3, in experiments not shown here we refined the location
of the HCF-1SAS1N and HCF-1SAS2N elements. The results of these experiments are summarized in Fig. 4. As shown in Fig. 3, HCF-1N1011
associated with both HCF-1SAS1C and to a lesser
extent with HCF-1SAS2C, whereas
HCF-1N450 associated effectively only with the
HCF-1SAS1C element. Consistent with the inability
of the minimal VP16 interaction region in HCF-1N380 to associate with the entire HCF-1C subunit (Fig.
2), HCF-1N380 did not exhibit association
with either the HCF-1SAS1C or
HCF-1SAS2C element. In these experiments, we mapped
the HCF-1SAS1N element to within HCF residues
348 to 450 (which we fused to the yeast GAL4 DNA-binding domain
owing to our inability to detect this and smaller HCF fragments of this
region on their own in our assay). Residues 382 to 450 alone,
however, which represent the region removed in the
alternative-splice variant of HCF, failed to associate with any of the
HCF-1C fragments (Fig. 4). Consistent with this mapping of the HCF-1SAS1N element, a fragment
covering residues 348 to 1011 (HCF-1N348-1011)
associated with all three of the HCF-1C fragments
used in the coimmunoprecipitation assay.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Summary of mapping of the HCF-1N SAS
elements. Each HCF-1N derivative was assayed for
association with HCF-1C (residues 1436 to 2035),
HCF-1SAS1C (residues 1758 to 2035), and
HCF-1SAS2C (residues 1436 to 1756) by
coimmunoprecipitation from transfected 293 cell extracts. The
interactions were scored as strong (+), weak (+/ ), or not detected
( ). HCF-1N348-450 and
HCF-1N382-450 were unstable as isolated
polypeptides and were assayed as fusions to the GAL4 DNA-binding domain
(residues 1 to 94).
|
|
Analysis of a selection of fragments containing portions of a region
enriched in basic residues (Fig.
1A)

HCF-1
N491-1011,
HCF-1
N836-1011,
HCF-1
N491-836, HCF-1
N491-755,
and HCF-1
N491-700
narrows the location of the
HCF-1
SAS2N element to within HCF residues 491 to
755 (Fig.
4). These results
show that a subregion of the basic region
contains the HCF-1
SAS2N element. Residues 813 to
847 within the basic region have recently
been shown to associate with
the transcription factor GA-binding
protein (GABP) (
25).
This association is unlikely to be related
to the SAS2N function
because these two elements of HCF-1 do not
overlap each other
(residues 491 to 755 [SAS2N] versus 813 to
847 [GABP association]).
The basic region has previously been implicated in cell proliferation,
and HCF-1
N sequences extending past residue 836 but
not beyond residue 902 are required to rescue the temperature-sensitive
defect in the hamster tsBN67 cell line (
26). The ability of
the HCF-1
N491-836 fragment to associate
effectively with
the HCF-1
SAS2C element suggests
that the HCF-1
SAS2N element does
not precisely
colocalize with the region that promotes cell proliferation
in tsBN67
cells, and thus one or more additional functions of
the basic region,
such as possibly association with GABP (
25),
are required to
rescue the tsBN67
defect.
Fine mapping of the paired HCF-1SAS1N and
HCF-1SAS1C elements.
To map one pair of SAS
elements in detail, we performed a deletion analysis of the
HCF-1SAS1N and HCF-1SAS1C elements
as shown in Fig. 5A. The results of the analysis shown
in Fig. 4 located the HCF-1SAS1N element to within
the 103-amino-acid HCF-1N348-450 fragment. This
region contains the carboxy-terminal residues of the
HCF-1KEL6 repeat (residues 348 to 360), which are
conserved among the HCF-1, HCF-2, and CeHCF proteins
(11, 16), and an additional region conserved among these
three proteins (residues 361 to 396) as shown in Fig. 5B. To locate the
HCF-1SAS1N element within residues 348 to 450, we
performed a more extensive deletion analysis of this region fused to
the GAL4 DNA-binding domain. As shown in Fig. 5A (lanes 1 to 3),
deletion of residues 348 to 360, but not to 382, had no apparent effect
on association with the HCF-1SAS1C-containing
HCF-1C1758-2035 fragment. Also, deletion of
residues 450 to 402, but not to 392, had no apparent effect on
association with the HCF-1C1758-2035 fragment (lanes 4 to 6), suggesting that the 43-amino-acid segment from 360 to
402 is sufficient to associate with the
HCF-1SAS1C element. Indeed, the 360-402 sequence
fused to the GAL4 DNA-binding domain is sufficient to associate with
the HCF-1C1758-2035 fragment (lane 7). Thus, the
SAS1N element resides within residues 360 to 402. Interestingly,
this region, which lies immediately adjacent to the
HCF-1KEL6 region, coincides with the 361-401
segment that is conserved among HCF-1, HCF-2, and CeHCF
(Fig. 5B).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 5.
Fine mapping of the HCF-1SAS1N and
HCF-1SAS1C regions. (A) HA-tagged
HCF-1N fragments (fused to GAL4 residues 1 to 94)
and T7-tagged HCF-1C fragments were coexpressed in
transfected 293T cells, and noncovalent association was assayed by
immunoprecipitation (IP) with the HA antibody followed by
immunoblotting with the T7 antibody. Truncations of the HA-tagged
HCF-1SAS1N domain were assayed by cotransfection
with pCGTHCF-1SAS1C (residues 1758 to 2035) and were as
follows: HCF-1N348-450 (lane 1),
HCF-1N360-450 (lane 2),
HCF-1N382-450 (lane 3),
HCF-1N348-420 (lane 4),
HCF-1N348-402 (lane 5),
HCF-1N348-392 (lane 6), and
HCF-1N360-402 (lane 7). Truncations of T7-tagged
HCF-1SAS1C domain were assayed by cotransfection
with the HA-tagged HCF-1SAS1N fragment (residues
348 to 450, pCGNGalHCF-1N348-450) and were as follows:
HCF-1C1758-2014 (lane 8),
HCF-1C1758-2002 (lane 9),
HCF-1C1758-1990 (lane 10),
HCF-1C1812-2035 (lane 11),
HCF-1C1819-2035 (lane 12), and
HCF-1C1812-2002 (lane 8). The two smallest
functional fragments HCF-1N360-402 and
HCF-1C1812-2002 were combined in lane 13. (B)
Alignment of the carboxy-terminal end of the
HCF-1KEL6 and HCFSAS1N sequences with
the corresponding regions of HCF-2 (11) and CeHCF
(16). Identical residues in all three sequences are
highlighted in black. The conservation extends beyond the last strand ( 3) of HCF-1KEL6, across the length of
the HCF-1SAS1N domain. Amino acid numbers below the
sequence refer to HCF-1.
|
|
We performed a similar analysis of the HCF-1
SAS1C
element (Fig.
5, lanes 8 to 13). Deletion of carboxy-terminal residues
2035
to 2002, but not to 1990, had no apparent effect on
association
with HCF-1
N348-450 (lanes 8 to 10),
and deletion of residues
1758 to 1812, but not to 1819, had only a
small deleterious effect
on association with
HCF-1
N348-450 (lanes 11 and 12). (Note
that the
HCF-1
SAS1C1812-2035 construct [lane 11]
consistently
produced a faster-migrating fragment that did not
associate with
HCF-1
N348-450; we do not know the
origin of this fragment.)
Consistent with these results, an
HCF-1
C1812-2002 fragment
can associate with the
HCF-1
N348-450 fragment (lane 13).
Indeed, the two
smallest fragments capable of HCF self-association

the
43-amino-acid
HCF-1
N360-402 fragment and the 191-amino-acid
HCF-1
C1812-2002 fragment

associate with one
another (lane
14). Interestingly, the HCF-1
SAS1C
element lies precisely within
the predicted
HCF
Fn3-repeat-containing carboxy-terminal region
that
is shared among the HCF-1, HCF-2, and CeHCF proteins
(residues
1812 to 2002 [Fig.
1B]). The close match between the
mapping results
and the boundaries of the proposed Fn3 repeats
strengthens the
prediction that the HCF-1 carboxyl terminus is
composed of a conserved
pair of Fn3 repeats, which together form
the HCF-1
SAS1C element.
Hughes et al. (
10) have reported a mapping analysis of the
HCF-1
SAS1 element using proteins synthesized in
vitro and an
assay involving retardation of the mobility of the
VP16-induced
complex during polyacrylamide gel electrophoresis. Their
analysis
mapped the HCF-1
SAS1N element to within
residues 1 to 450 and
the HCF-1
SAS1C to within
residues 1786 to 2035, consistent with
the in vivo association assay
described
here.
HCF-2 contains a conserved SAS1N element.
Unlike the
HCF-1 protein, HCF-2 and CeHCF do not contain any
HCF-1PRO processing repeats and there is no evidence
that HCF-2 and CeHCF are proteolytically processed
(11) (Y. Liu and W. Herr, unpublished results). Thus, there
is no a priori reason to expect the SAS elements of HCF-1 to be
conserved in HCF-2 and CeHCF. We were surprised, therefore, to
find that the sequences of both the small SAS1N (residues 360 to
402) and larger SAS1C (residues 1812 to 2002) elements are conserved in
the HCF-2 and CeHCF proteins (Fig. 1B and 5B). The sequence
conservation led us to ask whether HCF-2 contains a functional SAS1
element. Unfortunately, the carboxy-terminal HCF-2 segment
corresponding to HCF-1SAS1C could not be
synthesized effectively in transfected cells. We therefore tested the
ability of the putative amino-terminal SAS1 element (HCF-2 residues
341 to 394) to associate with the HCF-1SAS1C region
as shown in Fig. 6. Consistent with an
HCF-2SAS1N function, this HCF-2341-394
segment could associate effectively with HCF-1SAS1C
(compare lanes 1 to 3). Thus, HCF-2 and perhaps CeHCF are
likely to possess HCF self-association activity.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 6.
HCFSAS1 function is conserved
between HCF-1 and HCF-2. T7-tagged
HCF-1C1758-2035 was coexpressed in transfected
293T cells with HA-tagged fragments (fused to GAL4 residues 1 to 94)
corresponding to residues 341 to 394 of HCF-2 (lane 1), 348 to 450 of HCF-1 (lane 2), and 382 to 450 of HCF-1 (lane 3).
HCF-1SAS1N and HCF-1SAS1C
association was assayed by coimmunoprecipitation (IP) with the HA
antibody followed by immunoblotting with the T7 antibody (upper
panel). Protein expression was confirmed by immunoblotting extracts
directly with the T7 (center panel; HCF-1C
polypeptides) or HA (lower panel; HCF-1C
polypeptides) antibody.
|
|
Association with the carboxy-terminal HCF-1C
subunit results in nuclear localization of the
HCF-1N subunit.
Immunofluorescence and
subcellular fractionation studies have shown that HCF-1 is
predominantly a nuclear protein (12-14, 29) and that
nuclear localization is determined by a consensus bipartite NLS
(5) at its carboxyl terminus
(KRPMSSPEMKSAPKKSK; residues 2015 to
2031) (14). Thus, when expressed separately, the
HCF-1C600 fragment accumulates in the nucleus (Fig.
7B) like the endogenous protein (Fig. 7F), and the
HCF-1N1011 fragment accumulates largely in the
cytoplasm (Fig. 7A). Deletion of the NLS sequence results in
HCF-1C remaining largely in the cytoplasm (Fig. 7B
and C).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 7.
Nuclear localization of the
HCF-1N subunit through association with the
HCF-1C subunit, visualized by Immunofluorescence of
transfected 293 cells using the HA (A, D, and E) or T7 (B and C)
primary antibody. Cells were transfected with plasmids
pCGNHCF-1N (A), pCGTHCF-1C (B),
pCGTHCF-1C NLS (C),
pCGNHCF-1N1011 and pCGTHCF-1C
(D), and pCGNHCF-1N1011 and
pCGTHCF-1C NLS (E). For comparison,
mock-transfected cells were probed with HCF-M2 ( endog.
HCFC [F]), a monoclonal antibody against HCF-1
(28).
|
|
The dependence of HCF-1 nuclear localization on a single sequence
at its carboxyl terminus suggests that following proteolytic
processing
of the precursor, HCF-1 self-association maintains
the
HCF-1
N subunit within the nucleus. To test this
hypothesis,
we asked whether, when synthesized separately in
the same cell,
the HCF-1
C subunit can affect the
subcellular localization of
the HCF-1
N
subunit. Indeed, synthesis of the wild-type
HCF-1
C600 subunit (Fig.
7D), but not the
HCF-1
C600
NLS subunit (Fig.
7E), resulted in nuclear
import of the HCF-1
N subunit. These results
show
that the HCF-1
C subunit can recruit the
HCF-1
N subunit to
the nucleus. Such an activity of
HCF-1 subunits could be important
for the nuclear retention of the
HCF-1
N subunit after nuclear
breakdown and
resynthesis as a result of
mitosis.
 |
DISCUSSION |
We have characterized the sequences required for
HCF-1N and HCF-1C subunit
association. To our surprise, this characterization revealed two
matched pairs of HCF-1N and
HCF-1C SAS elements: HCF-1SAS1,
consisting of HCF-1SAS1N and
HCF-1SAS1C partners, and HCF-1SAS2, consisting of HCF-1SAS2N
and HCF-1SAS2C partners. The positions of the two
sets of HCF-1 SAS elements are shown in Fig. 8A. The
HCF-1SAS1 pair of elements has been mapped with
considerable precision and represents a small 43-amino-acid
amino-terminal HCF-1SAS1N sequence (residues 360 to
402) immediately adjacent to the
-propeller-containing VP16
interaction domain and a larger 191-amino-acid carboxy-terminal
HCF-1SAS1C sequence (residues 1812 to 2002), which
contains a pair of Fn3-type repeats. The HCF-1SAS2
element has been less rigorously mapped: the
HCF-1SAS2N sequence lies within residues 491 to 755 in the so-called, basic region and the HCF-1SAS2C
sequence lies within residues 1436 to 1756, which contains the
so-called acidic region.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 8.
Summary of HCF-1 functional elements and model for
HCF-1 and HCF-2 self-association and association with putative
effector proteins. (A) Schematic of human HCF-1 (hHCF-1)
showing the locations of the two matched pairs of SAS elements (SAS1
and SAS2). The HCF-1SAS1 pair have been mapped to
residues 360 to 402 (SAS1N) and 1812 to 2002 (SAS1C). The
HCF-1SAS2 pair are less well defined and lie
between residues 491 and 755 (SAS2N) and residues 1436 and 1756 (SAS2C). Features of the HCF-1 illustration are as described in the
legend to Fig. 1A. (B) Self-association is likely to be regulated in
vivo. The proposed general structure of HCF-1 is shown in cartoon
form. Following proteolytic cleavage at the central HCFPRO
repeats, the HCF-1N and HCF-1C
subunits remain associated through noncovalent interactions mediated by
the two self-association domains present in each subunit. Subunit
interaction is required for the nuclear localization of
HCF-1N, which does not contain its own NLS. The
presence of two intersubunit contacts also allows for limited
dissociation. For example, following dissociation of the SAS1 pairing,
contacts between the two HCF-1 subunits may be maintained by the
SAS2 interaction. In this scenario, the SAS1 sequences are available
for interaction with other cellular proteins (X and Y), a dual function
that might explain the strong sequence conservation of the SAS1
sequences in HCF-2 and CeHCF. Because HCF-2 is not
proteolytically cleaved, there is no requirement for a second
noncovalent SAS2-like association.
|
|
Regulation of HCF-1N and
HCF-1C association.
The identification of two
separate SAS elements raises a paradox because deletion of just one
half of one of these sets, HCF-1SAS1N, inactivates
HCF-1 subunit association. These results suggest that amino-terminal HCF-1 sequences can inhibit the activity of the HCF-1SAS2N element. First, the entire
amino-terminal region of HCF-1 (residues 1 to 1011) associates less
well with the HCF-1SAS2C region than residues 450 to 1011 alone (Fig. 3); second, deletion of residues 380 to 452 in the
alternative-splice HCF-1 variant (Fig. 1), which impinges on the
HCF-1SAS1N but not the
HCF-1SAS2N sequence, prevents detectable
HCF-1C association. Thus, inactivation of
HCF-1SAS1N in this natural deletion variant also
functionally inactivates HCF-1SAS2N. Perhaps,
the region encompassing the HCF-1SAS1N sequence inhibits the activity of the HCF-1SAS2N
element, particularly when residues 382 to 450 are removed, providing
an efficient mechanism for regulation of HCF subunit association.
Whatever the case, this result shows that HCF-1SAS2
element is not simply due to nonspecific association of the basic and
acidic regions of HCF.
The HCF-1SAS1 association element is conserved
in HCF family members.
The SAS elements in HCF-1 were
identified because HCF-1 is processed to produce amino-terminal and
carboxy-terminal HCF subunits that remain associated (27).
We were very much surprised, therefore, to find that the sequence of
one of the paired HCF-1 SAS elements, HCF-1SAS1, is conserved in human HCF-2 and
C. elegans HCF (Fig. 1B and 5B), proteins that do not
display any evidence of proteolytic cleavage. Furthermore, the sequence
in HCF-2 corresponding to the HCF-1SAS1N
sequence can associate with the HCF-1SAS1C sequence (Fig. 6). Thus, even though there is no evidence that HCF-1 and HCF-2 associate with one another in vivo (K. M. Johnson and
A. C. Wilson, unpublished results), both proteins have conserved HCFSAS1N activity. As illustrated in Fig. 8B, we
hypothesize that the HCFSAS1 element has been conserved in
both proteins and retains self-association activity in HCF-2. Given
the sequence conservation in C. elegans HCF, we also suggest
that the C. elegans HCF protein possesses an active
HCF-1SAS1 element, although this possibility has
not been tested directly.
It is curious that HCF-2 (and perhaps
C. elegans HCF)
has conserved a SAS element when there is no evidence that it is
proteolytically
processed. It is also surprising that the
HCF-2
SAS1N element has
retained the ability to
associate with HCF-1 when there is no
reason to believe that these
proteins associate with one another
in vivo. Perhaps, the function of
the HCF-1
SAS1 element is not
only to associate with
itself but also to associate with effector
proteins in the cell (Fig.
8B). If, for example, the HCF-1
SAS1N and
HCF-2
SAS1N elements share effector proteins, then the
HCF
SAS1N element may have been conserved in both HCF-1
and HCF-2 to maintain
this interaction, a by-product being the
conserved ability of
the HCF-2
SAS1N element to
associate with the HCF-1
SAS1C element.
We do not know why HCF-2 may have conserved an SAS element. Its
conservation in HCF-2, however, helps explain why HCF-1
unexpectedly
has two SAS elements: the first, SAS1, may play a role in
both
HCF-1 and HCF-2 in addition to self-association. Because,
HCF-1,
unlike HCF-2, is proteolytically cleaved, the SAS2
element may
be essential in HCF-1 to maintain self-association, an
activity
not required in HCF-2 because it is not proteolytically
cleaved.
Fn3 repeats form a protein-protein interaction module.
The
sequence of the HCF-1SAS1C element exhibits
similarity to a tandem pair of Fn3 repeats. Fn3 repeats from different
proteins generally exhibit limited sequence similarity (2).
Structurally, however, all Fn3 repeats fold into two
sheets packed
against each other like a sandwich (3, 4, 9, 18). Thus, Fn3 repeats represent a conserved structure that can vary considerably in
sequence to create many different types of functional surfaces. This
flexibility may account for their widespread use (2).
Fn3 repeats mediate protein-protein interactions. In some instances, a
single repeat is sufficient (
20); in other instances,
multiple repeats are required for specific association (
21).
In HCF-1
SAS1C, both repeats are necessary for
association with
HCF-1
SAS1N (Fig.
5). Recently, de
Pereda et al. (
3) described
the structure of tandem Fn3
repeats from the cytoplasmic tail
of the
4 subunit of
integrin
6
4. This and other Fn3 repeat
structures suggest two ways in which tandem Fn3 repeats can associate
with other proteins. In one way, an Fn3 repeat can present short
peptide sequences on its surface that can bind other proteins
as in the
case of the RGD tripeptide sequence of the 10th Fn3
repeat of
fibronectin (
3). In the second way, tandem Fn3 repeats
can
form an extended groove that is an attractive docking site
for another
protein surface. If the HCF-1
SAS1C Fn3 repeats form
such a surface, it could be a docking site for the
HCF-1
SAS1N element and perhaps an effector protein
as illustrated in Fig.
8B.
Implications of the two-subunit composition of HCF-1 for its
function.
Consistent with earlier results (14), we have
identified a classical bipartite NLS at the extreme carboxyl terminus
of HCF-1. We have also shown that the HCF-1N
subunit does not contain an NLS and that HCF-1SAS1N
subunits can migrate to the nucleus through association with the
HCF-1SAS1C subunit. This arrangement resembles polymerase
primase, which is also composed of two stably associated subunits. In this case, a single NLS in the p54 subunit targets the
smaller p46 subunit to the nucleus (19). Pulse-chase
analysis of the HCF-1300 precursor has shown that
it migrates to the nucleus prior to its initial proteolytic cleavage
(29). Thus, HCF-1 subunit association is more likely to
be required for the nuclear retention of the HCF-1N
subunit rather than its initial nuclear import. Because HCF-1 is
stable (29), it may persist through multiple rounds of cell
division. Perhaps HCF-1 subunit association is required to maintain
the nuclear location of the HCF-1N subunit following nuclear breakdown and resynthesis as a result of mitosis.
The HCF-1
N and HCF-1
C subunits
perform different functions within the cell. The
HCF-1
N subunit associates with the viral and
cellular HCF-binding proteins VP16 (
15,
26), LZIP
(
6,
17),
and GABP (
25) and complements the
temperature-sensitive cell
proliferation defect in tsBN67 cells. As
shown here, the HCF-1
C subunit localizes the
HCF-1 protein in the nucleus, and it can
also stabilize
VP16-induced complex formation with full-length
VP16 (
15).
The regulated association of HCF-1 subunits, as evidenced
by the
alternative pre-mRNA splice variant, provides a unique
opportunity to
control the association of the different HCF-1
N and
HCF-1
C subunit functions in the cell. It will be
interesting
to determine whether HCF-1
N and
HCF-1
C subunit association is
temporally regulated
during phases of the cell cycle or in specific
cell
types.
 |
ACKNOWLEDGMENTS |
We thank David Spector and colleagues for advice on microscopy;
Andrew Neuwald for aid in the analysis of the HCF-1 Fn3 repeat similarity; and J. Duffy, M. Ockler, and P. Renna for artwork.
This study was supported by PHS grant GM54598 to W.H. and by
funds from the Kaplan Comprehensive Cancer Center and an
institutional award from the American Cancer Society (IRG-14-39)
to A.C.W.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Cold Spring
Harbor Laboratory, P.O. Box 100, Cold Spring Harbor, NY 11724. Phone:
(516) 367-8401. Fax: (516) 367-8454. E-mail: herr{at}cshl.org.
Present address: Department of Genetics, Harvard Medical
School, Boston, MA 02115.
Present address: Department of Biological Chemistry, University of
California, Los Angeles, School of Medicine, Los Angeles, CA 90095.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Campbell, I. D., and C. Spitzfaden.
1994.
Building proteins with fibronectin type III modules.
Structure
2:333-337[Medline].
|
| 3.
|
de Pereda, J. M.,
G. Wiche, and R. C. Liddington.
1999.
Crystal structure of a tandem pair of fibronectin type III domains from the cytoplasmic tail of integrin alpha6beta4.
EMBO J.
18:4087-4095[CrossRef][Medline].
|
| 4.
|
Dickinson, C. D.,
B. Veerapandian,
X. P. Dai,
R. C. Hamlin,
N. H. Xuong,
E. Ruoslahti, and K. R. Ely.
1994.
Crystal structure of the tenth type III cell adhesion module of human fibronectin.
J. Mol. Biol.
236:1079-1092[CrossRef][Medline].
|
| 5.
|
Dingwall, C., and R. A. Laskey.
1991.
Nuclear targeting sequences a consensus?
Trends Biochem. Sci.
16:478-481[CrossRef][Medline].
|
| 6.
|
Freiman, R. N., and W. Herr.
1997.
Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP.
Genes Dev.
11:3122-3127[Abstract/Free Full Text].
|
| 7.
|
Goto, H.,
S. Motomura,
A. C. Wilson,
R. N. Freiman,
Y. Nakabeppu,
K. Fukushima,
M. Fujishima,
W. Herr, and T. Nishimoto.
1997.
A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function.
Genes Dev.
11:726-737[Abstract/Free Full Text].
|
| 8.
|
Herr, W.
1998.
The herpes simplex virus VP16-induced complex: mechanisms of combinatorial transcriptional regulation.
Cold Spring Harbor Symp. Quant. Biol.
63:599-607[CrossRef][Medline].
|
| 9.
|
Huber, A. H.,
Y. M. Wang,
A. J. Bieber, and P. J. Bjorkman.
1994.
Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 Å.
Neuron
12:717-731[CrossRef][Medline].
|
| 10.
|
Hughes, T. A.,
S. LaBoissière, and P. O'Hare.
1999.
Analysis of functional domains of the host cell factor involved in VP16 complex formation.
J. Biol. Chem.
274:16437-16443[Abstract/Free Full Text].
|
| 11.
|
Johnson, K. M.,
S. S. Mahajan, and A. C. Wilson.
1999.
Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a novel family member, HCF-2.
J. Virol.
73:3930-3940[Abstract/Free Full Text].
|
| 12.
|
Kristie, T. M.,
J. L. Pomerantz,
T. C. Twomey,
S. A. Parent, and P. Sharp, A..
1995.
The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides.
J. Biol. Chem.
270:4387-4394[Abstract/Free Full Text].
|
| 13.
|
Kristie, T. M.,
J. L. Vogel, and A. E. Sears.
1999.
Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency.
Proc. Natl. Acad. Sci. USA
96:1229-1233[Abstract/Free Full Text].
|
| 14.
|
LaBoissière, S.,
T. Hughes, and P. O'Hare.
1999.
HCF-dependent nuclear import of VP16.
EMBO J.
18:480-489[CrossRef][Medline].
|
| 15.
|
LaBoissière, S.,
S. Walker, and P. O'Hare.
1997.
Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain.
Mol. Cell. Biol.
17:7108-7118[Abstract].
|
| 16.
|
Liu, Y.,
M. O. Hengartner, and W. Herr.
1999.
Selected elements of herpes simplex virus accessory factor HCF are highly conserved in Caenorhabditis elegans.
Mol. Cell. Biol.
19:909-915[Abstract/Free Full Text].
|
| 17.
|
Lu, R.,
P. Yang,
P. O'Hare, and V. Misra.
1997.
Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cell factor.
Mol. Cell. Biol.
17:5117-5126[Abstract].
|
| 18.
|
Main, A. L.,
T. S. Harvey,
M. Baron,
J. Boyd, and I. D. Campbell.
1992.
The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.
Cell
71:671-678[CrossRef][Medline].
|
| 19.
|
Mizuno, T.,
T. Okamoto,
M. Yokoi,
M. Izumi,
A. Kobayashi,
T. Hachiya,
K. Tamai,
T. Inoue, and F. Hanaoka.
1996.
Identification of the nuclear localization signal of mouse DNA primase: nuclear transport of p46 subunit is facilitated by interaction with p54 subunit.
J. Cell Sci.
109:2627-2636[Abstract].
|
| 20.
|
Moyano, J. V.,
B. Carnemolla,
C. Dominguez-Jimenez,
M. Garcia-Gila,
J. P. Albar,
P. Sanchez-Aparicio,
A. Leprini,
G. Querze,
L. Zardi, and A. Garcia-Pardo.
1997.
Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins.
J. Biol. Chem.
272:24832-24836[Abstract/Free Full Text].
|
| 21.
|
Nagai, T.,
N. Yamakawa,
S. Aota,
S. S. Yamada,
S. K. Akiyama,
K. Olden, and K. M. Yamada.
1991.
Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly.
J. Cell. Biol.
114:1295-1305[Abstract/Free Full Text].
|
| 22.
|
O'Hare, P.
1993.
The virion transactivator of herpes simplex virus.
Semin. Virol.
4:145-155.
|
| 23.
|
Schultz, J.,
F. Milpetz,
P. Bork, and C. P. Ponting.
1998.
SMART, a simple modular architecture research tool: identification of signaling domains.
Proc. Natl. Acad. Sci. USA
95:5857-5864[Abstract/Free Full Text].
|
| 24.
|
Sturm, R. A.,
G. Das, and W. Herr.
1988.
The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain.
Genes Dev.
2:1582-1599[Abstract/Free Full Text].
|
| 25.
|
Vogel, J. L., and T. M. Kristie.
2000.
The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.
EMBO J.
19:683-690[CrossRef][Medline].
|
| 26.
|
Wilson, A. C.,
R. N. Freiman,
H. Goto,
T. Nishimoto, and W. Herr.
1997.
VP16 targets an amino-terminal domain of HCF involved in cell-cycle progression.
Mol. Cell. Biol.
17:6139-6146[Abstract].
|
| 27.
|
Wilson, A. C.,
K. LaMarco,
M. G. Peterson, and W. Herr.
1993.
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein.
Cell
74:115-125[CrossRef][Medline].
|
| 28.
|
Wilson, A. C.,
J. E. Parrish,
H. F. Massa,
D. L. Nelson,
B. J. Trask, and W. Herr.
1995.
The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidney.
Genomics
25:462-468[CrossRef][Medline].
|
| 29.
|
Wilson, A. C.,
M. G. Peterson, and W. Herr.
1995.
The HCF repeat is an unusual proteolytic cleavage signal.
Genes Dev.
9:2445-2458[Abstract/Free Full Text].
|
Molecular and Cellular Biology, September 2000, p. 6721-6730, Vol. 20, No. 18
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Misaghi, S., Ottosen, S., Izrael-Tomasevic, A., Arnott, D., Lamkanfi, M., Lee, J., Liu, J., O'Rourke, K., Dixit, V. M., Wilson, A. C.
(2009). Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1. Mol. Cell. Biol.
29: 2181-2192
[Abstract]
[Full Text]
-
Wang, Z., Pandey, A., Hart, G. W.
(2007). Dynamic Interplay between O-Linked N-Acetylglucosaminylation and Glycogen Synthase Kinase-3-dependent Phosphorylation. Mol. Cell. Proteomics
6: 1365-1379
[Abstract]
[Full Text]
-
Vogel, J. L., Kristie, T. M.
(2006). Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors. Proc. Natl. Acad. Sci. USA
103: 6817-6822
[Abstract]
[Full Text]
-
Guelman, S., Suganuma, T., Florens, L., Swanson, S. K., Kiesecker, C. L., Kusch, T., Anderson, S., Yates, J. R. III, Washburn, M. P., Abmayr, S. M., Workman, J. L.
(2006). Host Cell Factor and an Uncharacterized SANT Domain Protein Are Stable Components of ATAC, a Novel dAda2A/dGcn5-Containing Histone Acetyltransferase Complex in Drosophila. Mol. Cell. Biol.
26: 871-882
[Abstract]
[Full Text]
-
Luciano, R. L., Wilson, A. C.
(2003). HCF-1 Functions as a Coactivator for the Zinc Finger Protein Krox20. J. Biol. Chem.
278: 51116-51124
[Abstract]
[Full Text]
-
Piluso, D., Bilan, P., Capone, J. P.
(2002). Host Cell Factor-1 Interacts with and Antagonizes Transactivation by the Cell Cycle Regulatory Factor Miz-1. J. Biol. Chem.
277: 46799-46808
[Abstract]
[Full Text]
-
Mahajan, S. S., Little, M. M., Vazquez, R., Wilson, A. C.
(2002). Interaction of HCF-1 with a Cellular Nuclear Export Factor. J. Biol. Chem.
277: 44292-44299
[Abstract]
[Full Text]
-
Luciano, R. L., Wilson, A. C.
(2002). An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP. Proc. Natl. Acad. Sci. USA
99: 13403-13408
[Abstract]
[Full Text]
-
Lee, S., Herr, W.
(2001). Stabilization but Not the Transcriptional Activity of Herpes Simplex Virus VP16-Induced Complexes Is Evolutionarily Conserved among HCF Family Members. J. Virol.
75: 12402-12411
[Abstract]
[Full Text]
-
Wysocka, J., Reilly, P. T., Herr, W.
(2001). Loss of HCF-1-Chromatin Association Precedes Temperature-Induced Growth Arrest of tsBN67 Cells. Mol. Cell. Biol.
21: 3820-3829
[Abstract]
[Full Text]
-
Zhou, H.-J., Wong, C.-M., Chen, J.-H., Qiang, B.-Q., Yuan, J.-G., Jin, D.-Y.
(2001). Inhibition of LZIP-mediated Transcription through Direct Interaction with a Novel Host Cell Factor-like Protein. J. Biol. Chem.
276: 28933-28938
[Abstract]
[Full Text]